Rituximab for Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Stella Pak, Tamer Abdelhak,Panayiotis Varelas

Austin Journal of Cancer and Clinical Research（2023）

引用 0|浏览0

暂无评分

摘要

Anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis is a severe, but potentially reversible autoimmune encephalitis, dominantly affecting children and young adult women [1]. Approximately 60% of patients with NMDA encephalitis have tumors containing nervous tissue, such as ovarian teratoma [2].

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要